Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Substituted pyrrolo[3,4-D]imidazoles for the treatment of MDM2/4 mediated diseases

Substituted pyrrolo[3,4-D]imidazoles for the treatment of MDM2/4 mediated diseases

US Patent 8815926 · Granted Aug 26, 2014

Estimated economic value: $14,069,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Aminopyridine derivatives and their use as selective ALK-2 inhibitors2025
Substituted 2,4-dioxotetrahydropyrimidines as intermediates in the synthesis of 2025
Hemagglutinin-binding peptide2025
Method for producing peptide compound2025
Compounds and compositions for inhibiting the activity of HIF2-alpha and their m2025
Formulations of influenza therapeutics2024
Biaryl derivatives as YAP/TAZ-TEAD protein-protein interaction inhibitors2024
Biaryl derivatives as YAP/TAZ-TEAD protein-protein interaction inhibitors2024
Biaryl derivatives as YAP/TAZ-TEAD protein-protein interaction inhibitors2024
Bicyclic compounds and their uses2024
Pyrazolyl derivatives useful as anti-cancer agents2023
Pyrazolyl derivatives useful as anti-cancer agents2023